The gene expression signature of metabolic dysfunction- associated steatotic liver disease from a multiomics perspective

키워드

참고문헌 (10)

1. Sookoian S, "Genetic pathways in nonalcoholic fatty liver disease : insights from systems biology", Hepatology, 72, pp.330~346 (2020)
2. Sookoian S, "Epigenetic regulation of insulin resistance in nonalcoholic fatty liver disease : impact of liver methylation of the peroxisome proliferator-activated receptor γ coactivator 1αpromoter", Hepatology, 52, pp.1992~2000 (2010)
3. Pirola CJ, "Metabolic dysfunction-associated fatty liver disease : advances in genetic and epigenetic implications", Curr Opin Lipidol, 33, pp.95~102 (2022)
4. Pirola CJ, "Cross talk between the liver microbiome and epigenome in patients with metabolic dysfunction-associated steatotic liver disease", EBioMedicine, 101, pp.104996~ (2024)
5. Murphy SK, "Relationship between methylome and transcriptome in patients with nonalcoholic fatty liver disease", Gastroenterology, 145, pp.1076~1087 (2013)
6. Oh S, "Identification of signature gene set as highly accurate determination of MASLD progression", Clin Mol Hepatol, 30, pp.247~262 (2024)
7. Sookoian S, "Genetics in non-alcoholic fatty liver disease : The role of risk alleles through the lens of immune response", Clin Mol Hepatol, 29(Suppl), pp.S184~S195 (2023)
8. Sookoian S, "Intrahepatic bacterial metataxonomic signature in non-alcoholic fatty liver disease", Gut, 69, pp.1483~1491 (2020)
9. Sookoian S, "Genetics of nonalcoholic fatty liver disease : from pathogenesis to therapeutics", Semin Liver Dis, 39, pp.124~140 (2019)
10. Sookoian S, "Genetic variation in long noncoding RNAs and the risk of nonalcoholic fatty liver disease", Oncotarget, 8, pp.22917~22926 (2017)

관련 논문AI추천